WASHINGTON, Nov 9 (Reuters) - ActivBiotics Inc. on Thursday cut the expected price of its planned initial public offering to between $8 and $10 per share from a previous range of $12 to $14.
WASHINGTON, Nov 9 (Reuters) - ActivBiotics Inc. on Thursday cut the expected price of its planned initial public offering to between $8 and $10 per share from a previous range of $12 to $14.
